Date: December 22, 2021 By:
New York Times article featuring Dr. Alter, Dr. Lemieux, Dr. Karim
The findings suggest some people may not have broadly neutralizing antibody responses to universal flu vaccines, but there is the potential to rescue immune response.
The Ragon’s Biosafety Level 3 lab plays a key role in translational studies of emerging viral infections
In a new study, researchers from the Ragon Institute of MGH, MIT and Harvard found that different IgG subclasses provide different amounts of protection against vaginal HIV transmission.